Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?

To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in...

Full description

Saved in:
Bibliographic Details
Published inClinical biochemistry Vol. 42; no. 9; pp. 791 - 795
Main Authors Tapan, Serkan, Dogru, Teoman, Tasci, Ilker, Ercin, Cemal Nuri, Ozgurtas, Taner, Erbil, Mehmet Kemal
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2009
Subjects
Online AccessGet full text
ISSN0009-9120
1873-2933
1873-2933
DOI10.1016/j.clinbiochem.2009.02.005

Cover

Abstract To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS ( n = 25) and compared to healthy controls ( n = 53). sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33 ± 0.27 vs 0.71 ± 0.37 ng/mL, p < 0.001 and 0.51 ± 0.45 vs 1.16 ± 1.31 mg/L, p = 0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin ( r = − 0.5, p < 0.001 and r = − 0.34, p = 0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance ( p = 0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.
AbstractList Objective - To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). Design and methods - The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n = 25) and compared to healthy controls (n = 53). Results - sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33 +/- 0.27 vs 0.71 +/- 0.37 ng/mL, p < 0.001 and 0.51 +/- 0.45 vs 1.16 +/- 1.31 mg/L, p = 0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r = - 0.5, p < 0.001 and r = - 0.34, p = 0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p = 0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. Conclusion - These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.
To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).OBJECTIVETo investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n=25) and compared to healthy controls (n=53).DESIGN AND METHODSThe soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n=25) and compared to healthy controls (n=53).sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33+/-0.27 vs 0.71+/-0.37 ng/mL, p<0.001 and 0.51+/-0.45 vs 1.16+/-1.31 mg/L, p=0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r=-0.5, p<0.001 and r=-0.34, p=0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p=0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP.RESULTSsCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33+/-0.27 vs 0.71+/-0.37 ng/mL, p<0.001 and 0.51+/-0.45 vs 1.16+/-1.31 mg/L, p=0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r=-0.5, p<0.001 and r=-0.34, p=0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p=0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP.These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.CONCLUSIONThese novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.
To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS (n=25) and compared to healthy controls (n=53). sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33+/-0.27 vs 0.71+/-0.37 ng/mL, p<0.001 and 0.51+/-0.45 vs 1.16+/-1.31 mg/L, p=0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin (r=-0.5, p<0.001 and r=-0.34, p=0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance (p=0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.
To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS ( n = 25) and compared to healthy controls ( n = 53). sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33 ± 0.27 vs 0.71 ± 0.37 ng/mL, p < 0.001 and 0.51 ± 0.45 vs 1.16 ± 1.31 mg/L, p = 0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin ( r = − 0.5, p < 0.001 and r = − 0.34, p = 0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance ( p = 0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.
Author Tasci, Ilker
Ozgurtas, Taner
Erbil, Mehmet Kemal
Ercin, Cemal Nuri
Tapan, Serkan
Dogru, Teoman
Author_xml – sequence: 1
  givenname: Serkan
  surname: Tapan
  fullname: Tapan, Serkan
  email: serkantapan7@yahoo.com
  organization: Department of Medical Biochemistry, Gulhane School of Medicine, 06108 Etlik, Ankara, Turkey
– sequence: 2
  givenname: Teoman
  surname: Dogru
  fullname: Dogru, Teoman
  organization: Department of Gastroenterology, Gulhane School of Medicine, Etlik, Ankara, Turkey
– sequence: 3
  givenname: Ilker
  surname: Tasci
  fullname: Tasci, Ilker
  organization: Department of Internal Medicine, Gulhane School of Medicine, Etlik, Ankara, Turkey
– sequence: 4
  givenname: Cemal Nuri
  surname: Ercin
  fullname: Ercin, Cemal Nuri
  organization: Department of Gastroenterology, Gulhane School of Medicine, Etlik, Ankara, Turkey
– sequence: 5
  givenname: Taner
  surname: Ozgurtas
  fullname: Ozgurtas, Taner
  organization: Department of Medical Biochemistry, Gulhane School of Medicine, 06108 Etlik, Ankara, Turkey
– sequence: 6
  givenname: Mehmet Kemal
  surname: Erbil
  fullname: Erbil, Mehmet Kemal
  organization: Department of Medical Biochemistry, Gulhane School of Medicine, 06108 Etlik, Ankara, Turkey
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19232335$$D View this record in MEDLINE/PubMed
BookMark eNqNUV1vFCEUJabGbqt_weCLfZrxArMzjC9Ns2o1aaKJ-kwYuNuyslCB3aT_Xia7GuOLTfi-5xzgnDNyEmJAQl4xaBmw_s2mNd6FyUVzh9uWA4wt8BZg-YQsmBxEw0chTsgCaqUZGYdTcpbzpm55J_tn5JSNXHAhlguy_xr9bvJIV-86oN7d6mDp3PPx_EuT0aMpLlCPe_SZ1tW18xOmcpFpfgg2xS2-pVeVHX7QEul9imVmxED1rXYhF6rLHaaYjZ9Hly-fk6dr7TO-OM7n5PuH999WH5ubz9efVlc3jemgL41BybVZMui1nPh6KRkzxujarAAD0HFpLB9tp2UnrbSw5r0dBtkxKYcehTgnrw-69U0_d5iL2rps0HsdMO6y6gc-CAbwX2A1WXZCsAp8eQTupi1adZ_cVqcH9dvSCrg8AEz9ak64VsYVPbtRknZeMVBziGqj_gpx1h8VcFVDrArjPwp_LnkEd3Xg1qRw7zCpbBwGg9almomy0T1C5RdcY77c
CitedBy_id crossref_primary_10_1371_journal_pone_0075178
crossref_primary_10_1016_j_plipres_2012_11_001
crossref_primary_10_1080_09537104_2017_1280146
crossref_primary_10_1016_j_clinbiochem_2010_12_003
crossref_primary_10_1016_j_metabol_2013_11_011
crossref_primary_10_1038_s41598_017_00933_y
crossref_primary_10_5551_jat_6346
crossref_primary_10_1042_CS20140566
crossref_primary_10_1016_j_atherosclerosis_2015_02_051
crossref_primary_10_1016_j_cca_2018_10_028
crossref_primary_10_1152_ajprenal_00039_2014
crossref_primary_10_1186_s40064_016_3085_5
crossref_primary_10_1007_s11906_017_0756_8
crossref_primary_10_1016_j_freeradbiomed_2012_03_002
crossref_primary_10_1515_tjb_2016_0150
crossref_primary_10_1038_srep41681
crossref_primary_10_1097_MCA_0b013e3283315984
crossref_primary_10_1007_s00125_012_2818_4
crossref_primary_10_1016_j_atherosclerosis_2015_11_008
crossref_primary_10_1016_j_ijcme_2014_08_006
crossref_primary_10_1016_j_atherosclerosis_2014_12_042
crossref_primary_10_1186_s13098_023_01088_9
crossref_primary_10_1155_2018_6539385
crossref_primary_10_1373_clinchem_2010_151043
crossref_primary_10_1177_0004563214541969
crossref_primary_10_3109_07853890_2014_895588
crossref_primary_10_1007_s00380_011_0228_z
Cites_doi 10.1002/jcb.240450206
10.1016/S0021-9150(96)05980-1
10.1016/0304-4165(93)90013-X
10.1161/01.STR.32.2.580-b
10.1016/S0021-9150(99)00033-7
10.1055/s-0038-1646169
10.1016/S0021-9150(97)00232-3
10.1161/01.ATV.0000118279.74056.8a
10.1016/j.mehy.2006.12.069
10.1016/S0735-1097(02)02718-3
10.1159/000133513
10.1161/01.CIR.100.6.614
10.1093/clinchem/41.10.1504
10.1016/S0021-9150(01)00601-3
10.1093/clinchem/46.11.1723
10.1161/hc4501.099312
10.1016/j.atherosclerosis.2007.11.022
10.1258/000456306778520034
10.1093/clinchem/18.6.499
10.1016/j.jacc.2007.02.052
10.1177/15353702-0322805-29
10.1073/pnas.92.10.4342
10.1161/hc4401.099447
10.1096/fasebj.9.10.7542213
10.1097/00004872-199512010-00030
10.1161/01.HYP.0000100443.09293.4F
10.1016/j.metabol.2005.08.019
10.1152/ajpheart.2000.278.5.H1613
10.1161/01.CIR.0000074043.46437.44
10.1161/01.RES.85.8.663
10.1161/ATVBAHA.107.153262
10.1007/PL00000776
10.1161/01.CIR.97.10.953
10.1001/jama.297.8.842
10.1042/CS20060047
10.1161/01.CIR.96.2.396
10.1016/j.atherosclerosis.2005.05.011
10.1016/S0002-9149(97)00945-4
10.1093/clinchem/40.1.18
10.1073/pnas.97.13.6930
10.1161/01.CIR.103.4.491
10.1097/00001721-199710000-00002
10.1055/s-0038-1649788
10.1161/01.ATV.16.2.250
10.1161/01.HYP.0000130484.20501.df
10.2174/187152906776092659
10.1016/j.atherosclerosis.2008.01.001
ContentType Journal Article
Copyright 2009
Copyright_xml – notice: 2009
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
DOI 10.1016/j.clinbiochem.2009.02.005
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1873-2933
EndPage 795
ExternalDocumentID 19232335
10_1016_j_clinbiochem_2009_02_005
S0009912009000885
Genre Journal Article
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29B
4.4
457
4G.
4R4
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
AAYJJ
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABOCM
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
G8K
GBLVA
HLW
HVGLF
HX~
HZ~
IHE
J1W
KOM
LCYCR
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
UNMZH
WUQ
X7M
XPP
YYP
YYQ
ZGI
ZUP
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABDPE
ABWVN
ACIEU
ACLOT
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEIPS
AEUPX
AFJKZ
AFPUW
AGQPQ
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
EFKBS
~HD
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7X8
ID FETCH-LOGICAL-c406t-ce82ac5106a8b2f5811cccaccad30c00428cd29d4a848d8d0f26d778418876e33
IEDL.DBID .~1
ISSN 0009-9120
1873-2933
IngestDate Thu Sep 04 23:12:12 EDT 2025
Sun Sep 28 01:09:02 EDT 2025
Mon Jul 21 06:03:50 EDT 2025
Thu Apr 24 23:05:24 EDT 2025
Wed Oct 01 05:19:55 EDT 2025
Fri Feb 23 02:25:26 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords sCD40L
Bilirubin
Gilbert's syndrome
sP-selectin
hs-CRP
Atherosclerosis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c406t-ce82ac5106a8b2f5811cccaccad30c00428cd29d4a848d8d0f26d778418876e33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19232335
PQID 20084331
PQPubID 23462
PageCount 5
ParticipantIDs proquest_miscellaneous_67273100
proquest_miscellaneous_20084331
pubmed_primary_19232335
crossref_citationtrail_10_1016_j_clinbiochem_2009_02_005
crossref_primary_10_1016_j_clinbiochem_2009_02_005
elsevier_sciencedirect_doi_10_1016_j_clinbiochem_2009_02_005
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-06-01
PublicationDateYYYYMMDD 2009-06-01
PublicationDate_xml – month: 06
  year: 2009
  text: 2009-06-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical biochemistry
PublicationTitleAlternate Clin Biochem
PublicationYear 2009
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Schwertner, Vítek (bib7) 2008; 198
Nakagami, Toyomura, Kinoshita, Morisawa (bib49) 1993; 1158
Denger, Jahn, Wende (bib32) 1999; 144
Hopkins, Wu, Hunt, James, Vincent, Williams (bib3) 1996; 16
Davì, Romano, Mezzetti (bib15) 1998; 97
Friedewald, Levy, Fredrickson (bib20) 1972; 18
Garlichs, John, Schmeisser (bib9) 2001; 104
Wagner (bib13) 1993; 70
Phipps (bib8) 2000; 97
Jialal, Devaraj, Venugopal (bib46) 2004; 44
Blann, Lip (bib39) 1997; 128
Blann, Dobrotova, Kubisz, McCollum (bib16) 1995; 74
Aukrust, Müller, Ueland, Berget, Aaser, Brunsvig (bib10) 1999; 100
Gokulakrishnan, Deepa, Mohan, Gross (bib35) 2006; 55
Ridker, Buring, Rifai (bib18) 2001; 103
Lip, Blann, Zarifis, Beevers, Lip, Beevers (bib14) 1995; 13
Varo, Nuzzo, Natal, Libby, Schönbeck (bib21) 2006; 111
van Es, Bout, Liu (bib1) 1993; 63
Varo, Vicent, Libby (bib11) 2003; 107
McCarty (bib44) 2007; 69
Ishizaka, Ishizaka, Takahashi, Yamakado, Hashimoto (bib26) 2001; 32
Breimer, Wannamethee, Ebrahim, Shaper (bib22) 1995; 41
Karmann, Hughes, Schechner, Fanslow, Pober (bib31) 1995; 92
McEver (bib36) 1990; 16
Schwertner, Jackson, Tolan (bib2) 1994; 40
Lindenblatt, Bordel, Schareck, Menger, Vollmar (bib41) 2004; 24
Vítek, Jirsa, Brodanová (bib23) 2002; 160
Ridker (bib45) 2007; 49
Novotny, Vítek (bib4) 2003; 228
Hirschfield, Alexander (bib19) 2006; 43
Tedder, Steeber, Chen, Engel (bib37) 1995; 9
Perlstein, Pande, Beckman, Creager (bib25) 2008; 28
Blann, Faragher, McCollum (bib40) 1997; 8
Mylonas, Kouretas (bib6) 1999; 13
Semb, van Wissen, Ueland (bib34) 2003; 41
Vachharajani, Work, Issekutz, Granger (bib42) 2000; 278
Schönbeck, Varo, Libby, Buring, Ridker (bib12) 2001; 104
Shimomura, Ogawa, Arai (bib17) 1998; 81
Mayer (bib48) 2000; 46
Yung, Leung, Yao, Chen, Huang (bib28) 2006; 6
Bjelakovic, Nikolova, Gluud, Simonetti, Gluud (bib29) 2007; 297
Mach, Schönbeck, Bonnefoy, Pober, Libby (bib33) 1997; 96
Schönbeck, Libby (bib30) 2001; 58
Taniyama, Griendling (bib27) 2003; 42
Bulmer, Blanchfield, Toth, Fassett, Coombes (bib5) 2008; 199
McEver (bib38) 1991; 45
Schwertner (bib24) 1998; 136
Hayashi, Takamiya, Yamaguchi (bib43) 1999; 85
Erdogan, Gullu, Yildirim (bib47) 2006; 184
van Es (10.1016/j.clinbiochem.2009.02.005_bib1) 1993; 63
Mach (10.1016/j.clinbiochem.2009.02.005_bib33) 1997; 96
Lip (10.1016/j.clinbiochem.2009.02.005_bib14) 1995; 13
Garlichs (10.1016/j.clinbiochem.2009.02.005_bib9) 2001; 104
Schwertner (10.1016/j.clinbiochem.2009.02.005_bib2) 1994; 40
Davì (10.1016/j.clinbiochem.2009.02.005_bib15) 1998; 97
Varo (10.1016/j.clinbiochem.2009.02.005_bib21) 2006; 111
Perlstein (10.1016/j.clinbiochem.2009.02.005_bib25) 2008; 28
Vachharajani (10.1016/j.clinbiochem.2009.02.005_bib42) 2000; 278
Novotny (10.1016/j.clinbiochem.2009.02.005_bib4) 2003; 228
Mylonas (10.1016/j.clinbiochem.2009.02.005_bib6) 1999; 13
Wagner (10.1016/j.clinbiochem.2009.02.005_bib13) 1993; 70
Friedewald (10.1016/j.clinbiochem.2009.02.005_bib20) 1972; 18
Phipps (10.1016/j.clinbiochem.2009.02.005_bib8) 2000; 97
Hirschfield (10.1016/j.clinbiochem.2009.02.005_bib19) 2006; 43
Mayer (10.1016/j.clinbiochem.2009.02.005_bib48) 2000; 46
Ridker (10.1016/j.clinbiochem.2009.02.005_bib45) 2007; 49
Blann (10.1016/j.clinbiochem.2009.02.005_bib16) 1995; 74
Bjelakovic (10.1016/j.clinbiochem.2009.02.005_bib29) 2007; 297
McEver (10.1016/j.clinbiochem.2009.02.005_bib36) 1990; 16
Schönbeck (10.1016/j.clinbiochem.2009.02.005_bib12) 2001; 104
Shimomura (10.1016/j.clinbiochem.2009.02.005_bib17) 1998; 81
Bulmer (10.1016/j.clinbiochem.2009.02.005_bib5) 2008; 199
Lindenblatt (10.1016/j.clinbiochem.2009.02.005_bib41) 2004; 24
Tedder (10.1016/j.clinbiochem.2009.02.005_bib37) 1995; 9
Vítek (10.1016/j.clinbiochem.2009.02.005_bib23) 2002; 160
Gokulakrishnan (10.1016/j.clinbiochem.2009.02.005_bib35) 2006; 55
Nakagami (10.1016/j.clinbiochem.2009.02.005_bib49) 1993; 1158
Blann (10.1016/j.clinbiochem.2009.02.005_bib40) 1997; 8
Yung (10.1016/j.clinbiochem.2009.02.005_bib28) 2006; 6
Schwertner (10.1016/j.clinbiochem.2009.02.005_bib7) 2008; 198
Jialal (10.1016/j.clinbiochem.2009.02.005_bib46) 2004; 44
Erdogan (10.1016/j.clinbiochem.2009.02.005_bib47) 2006; 184
Semb (10.1016/j.clinbiochem.2009.02.005_bib34) 2003; 41
Ishizaka (10.1016/j.clinbiochem.2009.02.005_bib26) 2001; 32
Breimer (10.1016/j.clinbiochem.2009.02.005_bib22) 1995; 41
Taniyama (10.1016/j.clinbiochem.2009.02.005_bib27) 2003; 42
Varo (10.1016/j.clinbiochem.2009.02.005_bib11) 2003; 107
McEver (10.1016/j.clinbiochem.2009.02.005_bib38) 1991; 45
Karmann (10.1016/j.clinbiochem.2009.02.005_bib31) 1995; 92
Ridker (10.1016/j.clinbiochem.2009.02.005_bib18) 2001; 103
Aukrust (10.1016/j.clinbiochem.2009.02.005_bib10) 1999; 100
Blann (10.1016/j.clinbiochem.2009.02.005_bib39) 1997; 128
McCarty (10.1016/j.clinbiochem.2009.02.005_bib44) 2007; 69
Schwertner (10.1016/j.clinbiochem.2009.02.005_bib24) 1998; 136
Hopkins (10.1016/j.clinbiochem.2009.02.005_bib3) 1996; 16
Hayashi (10.1016/j.clinbiochem.2009.02.005_bib43) 1999; 85
Schönbeck (10.1016/j.clinbiochem.2009.02.005_bib30) 2001; 58
Denger (10.1016/j.clinbiochem.2009.02.005_bib32) 1999; 144
References_xml – volume: 104
  start-page: 2395
  year: 2001
  end-page: 2400
  ident: bib9
  article-title: Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia
  publication-title: Circulation
– volume: 1158
  start-page: 189
  year: 1993
  end-page: 193
  ident: bib49
  article-title: A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin
  publication-title: Biochim. Biophys. Acta
– volume: 32
  start-page: 580
  year: 2001
  end-page: 583
  ident: bib26
  article-title: High serum bilirubin level is inversely associated with the presence of carotid plaque
  publication-title: Stroke
– volume: 228
  start-page: 568
  year: 2003
  end-page: 571
  ident: bib4
  article-title: Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies
  publication-title: Exp. Biol. Med.
– volume: 45
  start-page: 156
  year: 1991
  end-page: 161
  ident: bib38
  article-title: GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium
  publication-title: J. Cell. Biochem.
– volume: 160
  start-page: 449
  year: 2002
  end-page: 456
  ident: bib23
  article-title: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
  publication-title: Atherosclerosis
– volume: 100
  start-page: 614
  year: 1999
  end-page: 620
  ident: bib10
  article-title: Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
  publication-title: Circulation
– volume: 136
  start-page: 383
  year: 1998
  end-page: 387
  ident: bib24
  article-title: Association of smoking and low serum bilirubin antioxidant concentrations
  publication-title: Atherosclerosis
– volume: 111
  start-page: 341
  year: 2006
  end-page: 347
  ident: bib21
  article-title: Influence of pre-analytical and analytical factors on soluble CD40L measurements
  publication-title: Clin. Sci.
– volume: 24
  start-page: 601
  year: 2004
  end-page: 606
  ident: bib41
  article-title: Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 13
  start-page: 295
  year: 1999
  end-page: 309
  ident: bib6
  article-title: Lipid peroxidation and tissue damage
  publication-title: In Vivo
– volume: 13
  start-page: 1674
  year: 1995
  end-page: 1678
  ident: bib14
  article-title: Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report
  publication-title: J. Hypertens.
– volume: 18
  start-page: 499
  year: 1972
  end-page: 502
  ident: bib20
  article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin. Chem.
– volume: 49
  start-page: 2129
  year: 2007
  end-page: 2138
  ident: bib45
  article-title: C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus
  publication-title: J. Am. Coll. Cardiol.
– volume: 44
  start-page: 6
  year: 2004
  end-page: 11
  ident: bib46
  article-title: C-reactive protein: risk marker or mediator in atherothrombosis?
  publication-title: Hypertension
– volume: 103
  start-page: 491
  year: 2001
  end-page: 495
  ident: bib18
  article-title: Soluble P-selectin and the risk of future cardiovascular events
  publication-title: Circulation
– volume: 85
  start-page: 663
  year: 1999
  end-page: 671
  ident: bib43
  article-title: Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme
  publication-title: Circ. Res.
– volume: 74
  start-page: 626
  year: 1995
  end-page: 630
  ident: bib16
  article-title: von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
  publication-title: Thromb. Haemost.
– volume: 97
  start-page: 953
  year: 1998
  end-page: 957
  ident: bib15
  article-title: Increased levels of soluble P-selectin in hypercholesterolemic patients
  publication-title: Circulation
– volume: 63
  start-page: 114
  year: 1993
  end-page: 116
  ident: bib1
  article-title: Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37
  publication-title: Cytogenet. Cell Genet.
– volume: 198
  start-page: 1
  year: 2008
  end-page: 11
  ident: bib7
  article-title: Gilbert syndrome, UGT1A1⁎28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin
  publication-title: Atherosclerosis
– volume: 107
  start-page: 2664
  year: 2003
  end-page: 2669
  ident: bib11
  article-title: Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones
  publication-title: Circulation
– volume: 43
  start-page: 340
  year: 2006
  end-page: 343
  ident: bib19
  article-title: Gilbert's syndrome: an overview for clinical biochemists
  publication-title: Ann. Clin. Biochem.
– volume: 28
  start-page: 166
  year: 2008
  end-page: 172
  ident: bib25
  article-title: Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 144
  start-page: 15
  year: 1999
  end-page: 23
  ident: bib32
  article-title: Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis
  publication-title: Atherosclerosis
– volume: 92
  start-page: 4342
  year: 1995
  end-page: 4346
  ident: bib31
  article-title: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 41
  start-page: 275
  year: 2003
  end-page: 279
  ident: bib34
  article-title: Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: down regulatory effect of statin therapy
  publication-title: J. Am. Coll. Cardiol.
– volume: 55
  start-page: 237
  year: 2006
  end-page: 242
  ident: bib35
  article-title: Soluble P selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome—the Chennai Urban Rural Epidemiology Study
  publication-title: Metabolism
– volume: 104
  start-page: 2266
  year: 2001
  end-page: 2268
  ident: bib12
  article-title: Soluble CD40L and cardiovascular risk in women
  publication-title: Circulation
– volume: 58
  start-page: 4
  year: 2001
  end-page: 43
  ident: bib30
  article-title: The CD40/CD154 receptor/ligand dyad
  publication-title: Cell. Mol. Life Sci.
– volume: 70
  start-page: 105
  year: 1993
  end-page: 110
  ident: bib13
  article-title: The Weibel–Palade body: the storage granule for von Willebrand factor and P-selectin
  publication-title: Thromb. Haemost.
– volume: 16
  start-page: 250
  year: 1996
  end-page: 255
  ident: bib3
  article-title: Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 81
  start-page: 397
  year: 1998
  end-page: 400
  ident: bib17
  article-title: Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction
  publication-title: Am. J. Cardiol.
– volume: 40
  start-page: 18
  year: 1994
  end-page: 23
  ident: bib2
  article-title: Association of low serum concentration of bilirubin with increased risk of coronary artery
  publication-title: Clin. Chem.
– volume: 97
  start-page: 6930
  year: 2000
  end-page: 6932
  ident: bib8
  article-title: Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 128
  start-page: 135
  year: 1997
  end-page: 138
  ident: bib39
  article-title: Hypothesis: is soluble P-selectin a new marker of platelet activation?
  publication-title: Atherosclerosis
– volume: 297
  start-page: 842
  year: 2007
  end-page: 857
  ident: bib29
  article-title: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis
  publication-title: JAMA
– volume: 96
  start-page: 396
  year: 1997
  end-page: 399
  ident: bib33
  article-title: Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor
  publication-title: Circulation
– volume: 8
  start-page: 383
  year: 1997
  end-page: 390
  ident: bib40
  article-title: Increased soluble P-selectin following myocardial infarction. A new marker for the progression of atherosclerosis
  publication-title: Blood Coagul. Fibrinolysis
– volume: 278
  start-page: 1613
  year: 2000
  end-page: 1617
  ident: bib42
  article-title: Heme oxygenase modulates selectin expression in different regional vascular beds
  publication-title: Am. J. Physiol, Heart Circ. Physiol.
– volume: 6
  start-page: 1
  year: 2006
  end-page: 19
  ident: bib28
  article-title: Reactive oxygen species in vascular wall
  publication-title: Cardiovasc. Hematol. Disord. Drug Targets
– volume: 46
  start-page: 1723
  year: 2000
  end-page: 1727
  ident: bib48
  article-title: Association of serum bilirubin concentration with risk of coronary artery disease
  publication-title: Clin. Chem.
– volume: 199
  start-page: 390
  year: 2008
  end-page: 396
  ident: bib5
  article-title: Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection
  publication-title: Atherosclerosis
– volume: 184
  start-page: 431
  year: 2006
  end-page: 437
  ident: bib47
  article-title: Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima–media thickness in both men and women
  publication-title: Atherosclerosis
– volume: 42
  start-page: 1075
  year: 2003
  end-page: 1081
  ident: bib27
  article-title: Reactive oxygen species in the vasculature: molecular and cellular mechanisms
  publication-title: Hypertension
– volume: 16
  start-page: 73
  year: 1990
  end-page: 80
  ident: bib36
  article-title: Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium
  publication-title: Blood Cells
– volume: 41
  start-page: 1504
  year: 1995
  end-page: 1508
  ident: bib22
  article-title: Serum bilirubin and risk of ischemic heart disease in middle-aged British men
  publication-title: Clin. Chem.
– volume: 9
  start-page: 866
  year: 1995
  end-page: 873
  ident: bib37
  article-title: The selectins: vascular adhesion molecules
  publication-title: FASEB J.
– volume: 69
  start-page: 974
  year: 2007
  end-page: 994
  ident: bib44
  article-title: “Iatrogenic Gilbert syndrome”—a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin
  publication-title: Med. Hypotheses
– volume: 45
  start-page: 156
  year: 1991
  ident: 10.1016/j.clinbiochem.2009.02.005_bib38
  article-title: GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.240450206
– volume: 128
  start-page: 135
  year: 1997
  ident: 10.1016/j.clinbiochem.2009.02.005_bib39
  article-title: Hypothesis: is soluble P-selectin a new marker of platelet activation?
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(96)05980-1
– volume: 1158
  start-page: 189
  year: 1993
  ident: 10.1016/j.clinbiochem.2009.02.005_bib49
  article-title: A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/0304-4165(93)90013-X
– volume: 13
  start-page: 295
  year: 1999
  ident: 10.1016/j.clinbiochem.2009.02.005_bib6
  article-title: Lipid peroxidation and tissue damage
  publication-title: In Vivo
– volume: 32
  start-page: 580
  year: 2001
  ident: 10.1016/j.clinbiochem.2009.02.005_bib26
  article-title: High serum bilirubin level is inversely associated with the presence of carotid plaque
  publication-title: Stroke
  doi: 10.1161/01.STR.32.2.580-b
– volume: 144
  start-page: 15
  year: 1999
  ident: 10.1016/j.clinbiochem.2009.02.005_bib32
  article-title: Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(99)00033-7
– volume: 70
  start-page: 105
  year: 1993
  ident: 10.1016/j.clinbiochem.2009.02.005_bib13
  article-title: The Weibel–Palade body: the storage granule for von Willebrand factor and P-selectin
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0038-1646169
– volume: 136
  start-page: 383
  year: 1998
  ident: 10.1016/j.clinbiochem.2009.02.005_bib24
  article-title: Association of smoking and low serum bilirubin antioxidant concentrations
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(97)00232-3
– volume: 24
  start-page: 601
  year: 2004
  ident: 10.1016/j.clinbiochem.2009.02.005_bib41
  article-title: Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.0000118279.74056.8a
– volume: 69
  start-page: 974
  year: 2007
  ident: 10.1016/j.clinbiochem.2009.02.005_bib44
  article-title: “Iatrogenic Gilbert syndrome”—a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin
  publication-title: Med. Hypotheses
  doi: 10.1016/j.mehy.2006.12.069
– volume: 41
  start-page: 275
  year: 2003
  ident: 10.1016/j.clinbiochem.2009.02.005_bib34
  article-title: Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: down regulatory effect of statin therapy
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/S0735-1097(02)02718-3
– volume: 63
  start-page: 114
  year: 1993
  ident: 10.1016/j.clinbiochem.2009.02.005_bib1
  article-title: Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37
  publication-title: Cytogenet. Cell Genet.
  doi: 10.1159/000133513
– volume: 100
  start-page: 614
  year: 1999
  ident: 10.1016/j.clinbiochem.2009.02.005_bib10
  article-title: Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
  publication-title: Circulation
  doi: 10.1161/01.CIR.100.6.614
– volume: 41
  start-page: 1504
  year: 1995
  ident: 10.1016/j.clinbiochem.2009.02.005_bib22
  article-title: Serum bilirubin and risk of ischemic heart disease in middle-aged British men
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/41.10.1504
– volume: 160
  start-page: 449
  year: 2002
  ident: 10.1016/j.clinbiochem.2009.02.005_bib23
  article-title: Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(01)00601-3
– volume: 46
  start-page: 1723
  year: 2000
  ident: 10.1016/j.clinbiochem.2009.02.005_bib48
  article-title: Association of serum bilirubin concentration with risk of coronary artery disease
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/46.11.1723
– volume: 104
  start-page: 2395
  year: 2001
  ident: 10.1016/j.clinbiochem.2009.02.005_bib9
  article-title: Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia
  publication-title: Circulation
  doi: 10.1161/hc4501.099312
– volume: 199
  start-page: 390
  year: 2008
  ident: 10.1016/j.clinbiochem.2009.02.005_bib5
  article-title: Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2007.11.022
– volume: 43
  start-page: 340
  year: 2006
  ident: 10.1016/j.clinbiochem.2009.02.005_bib19
  article-title: Gilbert's syndrome: an overview for clinical biochemists
  publication-title: Ann. Clin. Biochem.
  doi: 10.1258/000456306778520034
– volume: 18
  start-page: 499
  year: 1972
  ident: 10.1016/j.clinbiochem.2009.02.005_bib20
  article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/18.6.499
– volume: 49
  start-page: 2129
  year: 2007
  ident: 10.1016/j.clinbiochem.2009.02.005_bib45
  article-title: C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2007.02.052
– volume: 228
  start-page: 568
  year: 2003
  ident: 10.1016/j.clinbiochem.2009.02.005_bib4
  article-title: Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies
  publication-title: Exp. Biol. Med.
  doi: 10.1177/15353702-0322805-29
– volume: 92
  start-page: 4342
  year: 1995
  ident: 10.1016/j.clinbiochem.2009.02.005_bib31
  article-title: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.92.10.4342
– volume: 104
  start-page: 2266
  year: 2001
  ident: 10.1016/j.clinbiochem.2009.02.005_bib12
  article-title: Soluble CD40L and cardiovascular risk in women
  publication-title: Circulation
  doi: 10.1161/hc4401.099447
– volume: 9
  start-page: 866
  year: 1995
  ident: 10.1016/j.clinbiochem.2009.02.005_bib37
  article-title: The selectins: vascular adhesion molecules
  publication-title: FASEB J.
  doi: 10.1096/fasebj.9.10.7542213
– volume: 13
  start-page: 1674
  year: 1995
  ident: 10.1016/j.clinbiochem.2009.02.005_bib14
  article-title: Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report
  publication-title: J. Hypertens.
  doi: 10.1097/00004872-199512010-00030
– volume: 42
  start-page: 1075
  year: 2003
  ident: 10.1016/j.clinbiochem.2009.02.005_bib27
  article-title: Reactive oxygen species in the vasculature: molecular and cellular mechanisms
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000100443.09293.4F
– volume: 55
  start-page: 237
  year: 2006
  ident: 10.1016/j.clinbiochem.2009.02.005_bib35
  article-title: Soluble P selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome—the Chennai Urban Rural Epidemiology Study
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2005.08.019
– volume: 278
  start-page: 1613
  year: 2000
  ident: 10.1016/j.clinbiochem.2009.02.005_bib42
  article-title: Heme oxygenase modulates selectin expression in different regional vascular beds
  publication-title: Am. J. Physiol, Heart Circ. Physiol.
  doi: 10.1152/ajpheart.2000.278.5.H1613
– volume: 107
  start-page: 2664
  year: 2003
  ident: 10.1016/j.clinbiochem.2009.02.005_bib11
  article-title: Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000074043.46437.44
– volume: 85
  start-page: 663
  year: 1999
  ident: 10.1016/j.clinbiochem.2009.02.005_bib43
  article-title: Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme
  publication-title: Circ. Res.
  doi: 10.1161/01.RES.85.8.663
– volume: 16
  start-page: 73
  year: 1990
  ident: 10.1016/j.clinbiochem.2009.02.005_bib36
  article-title: Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium
  publication-title: Blood Cells
– volume: 28
  start-page: 166
  year: 2008
  ident: 10.1016/j.clinbiochem.2009.02.005_bib25
  article-title: Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.107.153262
– volume: 58
  start-page: 4
  year: 2001
  ident: 10.1016/j.clinbiochem.2009.02.005_bib30
  article-title: The CD40/CD154 receptor/ligand dyad
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/PL00000776
– volume: 97
  start-page: 953
  year: 1998
  ident: 10.1016/j.clinbiochem.2009.02.005_bib15
  article-title: Increased levels of soluble P-selectin in hypercholesterolemic patients
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.10.953
– volume: 297
  start-page: 842
  year: 2007
  ident: 10.1016/j.clinbiochem.2009.02.005_bib29
  article-title: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis
  publication-title: JAMA
  doi: 10.1001/jama.297.8.842
– volume: 111
  start-page: 341
  year: 2006
  ident: 10.1016/j.clinbiochem.2009.02.005_bib21
  article-title: Influence of pre-analytical and analytical factors on soluble CD40L measurements
  publication-title: Clin. Sci.
  doi: 10.1042/CS20060047
– volume: 96
  start-page: 396
  year: 1997
  ident: 10.1016/j.clinbiochem.2009.02.005_bib33
  article-title: Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor
  publication-title: Circulation
  doi: 10.1161/01.CIR.96.2.396
– volume: 184
  start-page: 431
  year: 2006
  ident: 10.1016/j.clinbiochem.2009.02.005_bib47
  article-title: Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima–media thickness in both men and women
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.05.011
– volume: 81
  start-page: 397
  year: 1998
  ident: 10.1016/j.clinbiochem.2009.02.005_bib17
  article-title: Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction
  publication-title: Am. J. Cardiol.
  doi: 10.1016/S0002-9149(97)00945-4
– volume: 40
  start-page: 18
  year: 1994
  ident: 10.1016/j.clinbiochem.2009.02.005_bib2
  article-title: Association of low serum concentration of bilirubin with increased risk of coronary artery
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/40.1.18
– volume: 97
  start-page: 6930
  year: 2000
  ident: 10.1016/j.clinbiochem.2009.02.005_bib8
  article-title: Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.97.13.6930
– volume: 103
  start-page: 491
  year: 2001
  ident: 10.1016/j.clinbiochem.2009.02.005_bib18
  article-title: Soluble P-selectin and the risk of future cardiovascular events
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.4.491
– volume: 8
  start-page: 383
  year: 1997
  ident: 10.1016/j.clinbiochem.2009.02.005_bib40
  article-title: Increased soluble P-selectin following myocardial infarction. A new marker for the progression of atherosclerosis
  publication-title: Blood Coagul. Fibrinolysis
  doi: 10.1097/00001721-199710000-00002
– volume: 74
  start-page: 626
  year: 1995
  ident: 10.1016/j.clinbiochem.2009.02.005_bib16
  article-title: von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0038-1649788
– volume: 16
  start-page: 250
  year: 1996
  ident: 10.1016/j.clinbiochem.2009.02.005_bib3
  article-title: Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.16.2.250
– volume: 44
  start-page: 6
  year: 2004
  ident: 10.1016/j.clinbiochem.2009.02.005_bib46
  article-title: C-reactive protein: risk marker or mediator in atherothrombosis?
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000130484.20501.df
– volume: 6
  start-page: 1
  year: 2006
  ident: 10.1016/j.clinbiochem.2009.02.005_bib28
  article-title: Reactive oxygen species in vascular wall
  publication-title: Cardiovasc. Hematol. Disord. Drug Targets
  doi: 10.2174/187152906776092659
– volume: 198
  start-page: 1
  year: 2008
  ident: 10.1016/j.clinbiochem.2009.02.005_bib7
  article-title: Gilbert syndrome, UGT1A1⁎28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2008.01.001
SSID ssj0002486
Score 2.0408452
Snippet To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble...
Objective - To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS)....
To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS).OBJECTIVETo...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 791
SubjectTerms Adult
Atherosclerosis
Atherosclerosis - blood
Atherosclerosis - prevention & control
Bilirubin
C-Reactive Protein - metabolism
CD40 Ligand - blood
Enzyme-Linked Immunosorbent Assay
Female
Gilbert Disease - blood
Gilbert's syndrome
hs-CRP
Humans
Male
P-Selectin - blood
sCD40L
sP-selectin
Young Adult
Title Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?
URI https://dx.doi.org/10.1016/j.clinbiochem.2009.02.005
https://www.ncbi.nlm.nih.gov/pubmed/19232335
https://www.proquest.com/docview/20084331
https://www.proquest.com/docview/67273100
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1873-2933
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002486
  issn: 0009-9120
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1873-2933
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002486
  issn: 0009-9120
  databaseCode: ACRLP
  dateStart: 20080401
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Freedom Collection Journals
  customDbUrl:
  eissn: 1873-2933
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002486
  issn: 0009-9120
  databaseCode: AIKHN
  dateStart: 20080401
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1873-2933
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002486
  issn: 0009-9120
  databaseCode: AKRWK
  dateStart: 19670101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED9CC9leRtd9NOuXBoM9ebFly1ZKoYS0abqRsIcV-mYkSykemVNmZ4_923tny8v2EAgUbGOEBIdO0p3u43cAn4JEi9jgBhSJb70o4dpDMWI8HesY1SMjEkN2yOksntxGX-_EXQdGbS4MhVW6s7850-vT2rX03Wz2H_KccnxRuwnIuk-CTFKiOaF_4Zr-8rgO8-BRXe2ROnvUuwsf1zFelH2ocypN9ctBVxJ8p9gkozbpoLUsGu_BK6dEsmFD52vo2GIfXoza2m370J06l_kb-EOGL72wbHQZ-WyR36vCMHpL1_7dK-taOHnBFhRBVDL8u84J-6r6XLIW0uCMDRl5e1m1ZA7cAVnK1L3KUcNktSK5LJEc_OblxVu4HV_9GE08V2zBy1CmV15mJVcZ7tBYSc3nQgZBhtzFx4R-Vl-tMsMHJlIykkYaf85jk5DXEo-p2IbhO9gploU9AIY3ulAoHWR6TmhxQiUqsX5og4GWhDfWA9lOb5o5JHIqiLFI25Czn-k_nKFKmYPU5ylypgf879CHBo5jm0HnLQ_T_9ZWimJjm-GnLd9TZCM5VFRhl6uyLuFJGWebe5Cfm1woPXjfLJg11ahZ8zAUH55H3CG8bPxbZBc6gp3q98oeo5pU6ZN6H5zA7vDm22T2BEN7EuM
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1RS9xAEB7sCepLsWrrVa1bKPgUTDbZZE8K5bjWntU7fFDwbdnN7knKmRMT-_s7k2y0PhwIhSSEZQeGnd2Z2ZndbwC-RJkRqcUFKLLQBUnGTYBmxAYmNSm6R1ZkluKQk2k6vk5-3YibFRh1d2HoWKXX_a1Ob7S1bzn2o3l8XxR0xxe9m4ii-2TIpHgDq4lAndyD1eHZ-Xj6pJB50hR8pP4BEazB5-djXnQB0RRUnerOo1cSgqdYZqaWuaGNOTrdhLfej2TDltV3sOLKLVgfdeXbtmBt4rPm2_CHYl9m7tjoexKyeXGrS8vorXz7ZVA15XCKks3pEFHF8O9nQfBX9VHFOlSDEzZklPBl9YJ5fAeUKtO3ukAnkzW-5KJCdvBbVN924Pr0x9VoHPh6C0GOZr0Ocie5znGRploaPhMyinIUMD42DvNmd5VbPrCJlom00oYzntqMEpeoqVIXx--hVy5KtwsMN3Wx0CbKzYwA44TOdObC2EUDIwlyrA-yG16VezByqokxV92ps9_qH8lQscyBCrlCyfSBP5Het4gcryH62slQvZheCi3Ha8gPO7krFCPlVHTpFo9VU8WTLp0t70Gpbsqi9OFDO2GeuUbnmsex-Ph_zB3C-vhqcqEuzqbne7DRprsoTLQPvfrh0R2g11SbT35V_AWKMRWO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Soluble+CD40+ligand+and+soluble+P-selectin+levels+in+Gilbert%27s+syndrome%3A+A+link+to+protection+against+atherosclerosis%3F&rft.jtitle=Clinical+biochemistry&rft.au=Tapan%2C+Serkan&rft.au=Dogru%2C+Teoman&rft.au=Tasci%2C+Ilker&rft.au=Ercin%2C+Cemal+Nuri&rft.date=2009-06-01&rft.pub=Elsevier+Inc&rft.issn=0009-9120&rft.eissn=1873-2933&rft.volume=42&rft.issue=9&rft.spage=791&rft.epage=795&rft_id=info:doi/10.1016%2Fj.clinbiochem.2009.02.005&rft.externalDocID=S0009912009000885
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9120&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9120&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9120&client=summon